Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
LRP2 is a potential molecular target for nonsyndromic pathological myopia
Kimberley Delaunay, … , Olivier Cases, Francine Behar-Cohen
Kimberley Delaunay, … , Olivier Cases, Francine Behar-Cohen
Published June 24, 2025
Citation Information: JCI Insight. 2025;10(15):e192929. https://doi.org/10.1172/jci.insight.192929.
View: Text | PDF
Research Article Neuroscience Ophthalmology

LRP2 is a potential molecular target for nonsyndromic pathological myopia

  • Text
  • PDF
Abstract

High myopia (HM) and posterior staphyloma (PS) are major causes of vision loss worldwide. Genetic and environmental factors, especially light exposure, influence myopia. This study shows that low-density lipoprotein–related receptor type 2 (LRP2) levels are decreased in the vitreous of patients with HM and PS, and that in human donor eyes affected by PS, LRP2 expression was reduced in the neural retina and retinal pigment epithelium (RPE), with morphologic changes similar to those observed in the Foxg1-Cre-Lrp2fl/fl mouse that also develops PS. In human induced pluripotent stem cell–derived RPE cells, LRP2 silencing regulated genes involved in eye and neuronal development, visual perception, tissue remodeling, hormone metabolism, and RPE structure. Its expression increased under light exposure, particularly red light, but was downregulated by cortisol. These findings establish a link between LRP2, myopization, and environmental factors, highlighting its crucial role in nonsyndromic HM and PS. LRP2 appears to be a promising therapeutic target for HM treatment.

Authors

Kimberley Delaunay, Emilie Picard, Patricia Lassiaz, Laurent Jonet, Vidjea Cannaya, José Maria Ruiz-Moreno, Kentaro Kojima, Henrik Vorum, Bent Honoré, Jorge Ruiz-Medrano, Lasse Jørgensen Cehofski, Eric Pussard, Renata Kozyraki, Alicia Torriglia, Olivier Cases, Francine Behar-Cohen

×

Figure 7

Differentially expressed genes (DEGs) between siLRP2 and scrambled iRPE cells.

Options: View larger image (or click on image) Download as PowerPoint
Differentially expressed genes (DEGs) between siLRP2 and scrambled iRPE ...
(A) Lrp2 mRNA quantification between scrambled (n = 4) and siLRP2 (n = 4) iRPE (*P < 0.05). (B) LRP2 levels as expressed by the ratio LRP2/GAPDH between scrambled (n = 4) and siLRP2 (n = 4) iRPE (**P < 0.01). (C) Volcano plot of DEGs between siLRP2 and scrambled iRPE cells with –log10 of the adjusted P value on the y axis and log2 of the fold change in expression on the x axis. Some genes, including LRP2, are indicated. (D) Category netplot gene enrichment analysis considering only LRP2 as a common factor with 3 GO terms (sensory perception, import across plasma membrane, and steroid metabolic processes) and (E) with 2 Reactome terms (sensory perception, visual transduction and metabolism). Fold change (color codes on each graph) for each gene of the selected GO term is indicated. Analysis was performed using Metascape (https://metascape.org/). Absolute normalized enrichment allowed identifying terms that were upregulated or downregulated using all DEGs.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts